Addus HomeCare Co. (NASDAQ:ADUS) Shares Acquired by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. increased its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 127.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 64,311 shares of the company’s stock after acquiring an additional 36,071 shares during the period. Harbor Capital Advisors Inc. owned about 0.36% of Addus HomeCare worth $8,555,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. UMB Bank n.a. raised its position in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the period. Quest Partners LLC acquired a new position in Addus HomeCare in the 2nd quarter worth about $31,000. EntryPoint Capital LLC acquired a new position in Addus HomeCare in the 1st quarter worth about $44,000. Innealta Capital LLC purchased a new position in Addus HomeCare during the second quarter worth approximately $44,000. Finally, Farther Finance Advisors LLC grew its holdings in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares in the company, valued at $429,165. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock worth $3,050,082 in the last ninety days. 4.60% of the stock is owned by insiders.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $126.27 on Friday. Addus HomeCare Co. has a 1-year low of $80.68 and a 1-year high of $136.12. The stock has a market cap of $2.29 billion, a P/E ratio of 29.92, a P/E/G ratio of 2.28 and a beta of 1.04. The stock’s 50 day simple moving average is $130.02 and its 200-day simple moving average is $120.27.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. During the same period in the prior year, the business earned $0.94 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. As a group, research analysts expect that Addus HomeCare Co. will post 4.57 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on ADUS shares. TD Cowen increased their target price on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Oppenheimer increased their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. KeyCorp started coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. Stephens reaffirmed an “overweight” rating and issued a $138.00 price target on shares of Addus HomeCare in a research note on Tuesday, August 6th. Finally, StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus price target of $131.38.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.